Number of the records: 1  

Interleukin-4, hemopexin, and lipoprotein-associated phospholipase A2 are significantly increased in patients with unstable carotid plaque

  1. TitleInterleukin-4, hemopexin, and lipoprotein-associated phospholipase A2 are significantly increased in patients with unstable carotid plaque
    Author Štefanič Peter
    Co-authors Sihotský Vladimír

    Hertelyová Zdenka

    Kopolovets Ivan

    Mathews Abraham John

    Tóth Štefan

    Kubíková Mária

    Svajdler Peter

    Mucha Rastislav 1982 SAVNEBIO - Neurobiologický ústav SAV    SCOPUS    RID    ORCID

    Vaško Lukáš

    Virag Michal

    Pribula Vit

    Pella Dominik

    Frankovičová Mária

    Source document Open Chemistry. Vol. 17 (2019) p. 1105-1115
    Languageeng - English
    NoteVEGA 1/0684/17; No. 1/GSD/2016
    URLURL link
    Document kindrozpis článkov z periodík (rbx)
    CitationsSHIN, Miji - PARK, Sang Hyun - MUN, Sora - LEE, Jiyeong - KANG, Hee-Gyoo. Biomarker Discovery of Acute Coronary Syndrome Using Proteomic Approach. In MOLECULES, 2021, vol. 26, no. 4, pp.
    SARIL, Ahmet - KOCATURK, Meric - SHIMADA, Kazumi - UEMURA, Akiko - AKGUN, Emel - LEVENT, Pinar - BAYKAL, Ahmet Tarik - PRIETO, Alberto Munoz - AGUDELO, Carlos Fernando - TANAKA, Ryou - CERON, Jose Joaquin - KOCH, Jorgen - YILMAZ, Zeki. Serum Proteomic Changes in Dogs with Different Stages of Chronic Heart Failure. In ANIMALS, 2022, vol. 12, no. 4, pp. ISSN 2076-2615. Dostupné na: https://doi.org/10.3390/ani12040490.
    CategoryADCA - Scientific papers in foreign journals registered in Current Contents Connect with IF (impacted)
    Category of document (from 2022)V3 - Vedecký výstup publikačnej činnosti z časopisu
    Type of documentčlánok
    Year2019
    Registered inWOS
    Registered inSCOPUS
    Registered inCCC
    DOI 10.1515/chem-2019-0125
    article

    article

    rokCCIFIF Q (best)JCR Av Jour IF PercSJRSJR Q (best)CiteScore
    A
    rok vydaniarok metrikyIFIF Q (best)SJRSJR Q (best)
    201920181.512Q30.345Q2
Number of the records: 1  

  This site uses cookies to make them easier to browse. Learn more about how we use cookies.